Next, for the TFAP2B gene, the survival curve analysis (Figure 8B) showed that the higher gene expression level is connected to shorter survival in lung cancer patients (p = 0.046); surprisingly, this finding is reversed for LUAD patients, for whom lower TFAP2B expression was associated with decreased patient survival rates (p = 0.015), and the significance is lost for LUSC subtype (p = 0.17). This evidence concerns the gene TFAP2B and lung carcinoma.